| Literature DB >> 27680539 |
J Sepúlveda-Delgado1, O L Vera-Lastra2,3, K Trujillo-Murillo4, L M Canseco-Ávila4, R A Sánchez-González4, O Gómez-Cruz5, A Lugo-Trampe6, I Fernández-Salas7, R Danis-Lozano7, A Contreras-Contreras8, A Mendoza-Torres8, S Domínguez-Arrevillaga4, B A Mena-Vela9, M Ocaña-Sibilla9, J C Ramirez-Valdespino9, L J Jara3,10.
Abstract
The chikungunya virus (ChikV) is a reemerging mosquito-borne pathogen that causes disabling chronic arthritis. The relationship between clinical evolution and inflammatory biomarkers in patients with ChikV-induced arthritis has not been fully described. We performed a prospective case series to evaluate the association among joint involvement, self-reported disability, and inflammatory biomarkers. Patients with ChikV infection were followed for 1 year. Joint involvement and self-reported disability were evaluated with disease activity index 28 (DAS-28) and World Health Organization Disablement Assessment Schedule II (WHODAS-II). Interleukin-6 (IL-6), C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and rheumatoid factor (RF) were used as biomarkers. Ten patients with mean age 48 ±15.04 years were included. Symptoms at diagnosis were fever, arthralgias, myalgias, rash, arthritis, nausea, vomiting, and back pain. Polyarticular involvement was present in seven cases. At diagnosis, measures were as follows: DAS-28, 5.08±1.11; WHODAS-II score, 72.3±10.3 %; CRP, 5.09±7.23 mg/dL; ESR, 33.5±17.5 mm/h; RF, 64±21.7 IU/mL; and IL-6, 17.6±10.3 pg/mL. Six patients developed subacute and chronic symptoms. During follow-up, DAS-28 index, WHODAS-II score, ESR, and IL-6 were statistically different in patients with subacute and chronic symptoms compared to those who resolved in the acute phase (p < 0.05). DAS-28 index, WHODAS-II score, and IL-6 were related to chronicity of articular symptoms and could be used as predictors of ChikV-induced arthritis.Entities:
Keywords: Chikungunya virus; Chronic arthritis; Disability; Il-6
Mesh:
Substances:
Year: 2016 PMID: 27680539 DOI: 10.1007/s10067-016-3419-2
Source DB: PubMed Journal: Clin Rheumatol ISSN: 0770-3198 Impact factor: 3.650